Physician
Salim Ortiz, Jadiyi
Salim Ortiz, Jadiyi was paid $3.05M by Medicaid between Jan 2018 and Dec 2024, across 97 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 30% of everything it billed.
33Billing provider infoSALIM ORTIZ, JADIYI
WHITE PLAINS, NY 10605
WHITE PLAINS, NY 10605
33aNPI1831295310assigned 09/15/2006
33bProvider typePediatrics Physician
28Total paid$3.05M
24GClaims132,096
24DCodes billed97
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#108 of 1,983
Median peer was paid$17K
This provider vs. median180×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,303 | $378K | |
| 2019 | 18,429 | $396K | |
| 2020 | 26,734 | $422K | |
| 2021 | 22,152 | $566K | |
| 2022 | 20,819 | $549K | |
| 2023 | 19,594 | $459K | |
| 2024incomplete | 13,065 | $278K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 30% | 17,407 | 15,582 | $913K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 10% | 2,793 | 2,790 | $311K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 9.0% | 2,519 | 2,392 | $276K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.9% | 2,383 | 2,347 | $271K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.4% | 9,047 | 8,811 | $255K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.5% | 1,650 | 1,591 | $169K |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | 5.0% | 7,063 | 6,877 | $153K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.6% | 1,723 | 1,661 | $141K |
| 99442 | 3.6% | 1,676 | 1,608 | $109K | |
| 92550 | 2.4% | 3,323 | 3,321 | $74K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 1,585 | 1,541 | $74K |
| 92587 | 1.5% | 2,063 | 1,909 | $46K |
85 more codes
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 1.4% | 1,615 | $44K |
| 83655 | <1% | 2,264 | $30K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,902 | $25K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,116 | $24K |
| 36410 | <1% | 1,231 | $23K | |
| 99173 | <1% | 6,079 | $16K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 137 | $15K |
| 0071A | <1% | 245 | $9K | |
| 0072A | <1% | 241 | $9K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 309 | $6K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,280 | $5K |
| 36406 | <1% | 271 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,486 | $4K |
| 87110 | <1% | 629 | $4K | |
| 97802 | <1% | 1,547 | $4K | |
| H0001 | Alcohol and/or drug assessment | <1% | 1,276 | $4K |
| 0001A | <1% | 91 | $3K | |
| 0002A | <1% | 79 | $3K | |
| 87081 | <1% | 646 | $3K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 210 | $3K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 48 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 26 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 37 | $2K |
| 99441 | <1% | 77 | $2K | |
| 99443 | <1% | 22 | $2K | |
| 92567 | <1% | 546 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 344 | $1K |
| 99382 | <1% | 12 | $1K | |
| 0081A | <1% | 18 | $720.00 | |
| 0082A | <1% | 13 | $520.00 | |
| 90650 | <1% | 254 | $453.03 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 97 | $415.71 |
| 99408 | <1% | 2,734 | $198.64 | |
| 90620 | <1% | 243 | $175.64 | |
| 4124F | <1% | 16 | $137.40 | |
| 86580 | <1% | 13 | $132.61 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 1,996 | $111.15 |
| 90688 | <1% | 691 | $48.09 | |
| 91307 | <1% | 418 | $19.82 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 48 | $9.81 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 15 | $4.89 |
| 99080 | 0% | 9,422 | $0.00 | |
| 3016F | 0% | 1,589 | $0.00 | |
| 90670 | 0% | 979 | $0.00 | |
| G9820 | Documentation of a chlamydia screening test with proper follow-up | 0% | 1,102 | $0.00 |
| 3725F | 0% | 2,964 | $0.00 | |
| 90734 | 0% | 341 | $0.00 | |
| 90649 | 0% | 257 | $0.00 | |
| 90633 | 0% | 464 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 192 | $0.00 |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 2,406 | $0.00 |
| 90648 | 0% | 326 | $0.00 | |
| G9821 | No documentation of a chlamydia screening test with proper follow-up | 0% | 206 | $0.00 |
| 1159F | 0% | 200 | $0.00 | |
| 90700 | 0% | 122 | $0.00 | |
| 90707 | 0% | 118 | $0.00 | |
| 90685 | 0% | 259 | $0.00 | |
| 91308 | 0% | 32 | $0.00 | |
| 90710 | 0% | 86 | $0.00 | |
| 90658 | 0% | 276 | $0.00 | |
| 91300 | 0% | 166 | $0.00 | |
| 90655 | 0% | 154 | $0.00 | |
| 90713 | 0% | 25 | $0.00 | |
| 90715 | 0% | 52 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 15 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 39 | $0.00 |
| 90661 | 0% | 294 | $0.00 | |
| 1036F | 0% | 2,345 | $0.00 | |
| 1000F | 0% | 2,938 | $0.00 | |
| 2000F | 0% | 2,394 | $0.00 | |
| 2010F | 0% | 2,371 | $0.00 | |
| G9275 | Documentation that patient is a current non-tobacco user | 0% | 2,940 | $0.00 |
| 99000 | 0% | 14 | $0.00 | |
| 3008F | 0% | 6,371 | $0.00 | |
| 90619 | 0% | 194 | $0.00 | |
| 2001F | 0% | 2,385 | $0.00 | |
| 90716 | 0% | 129 | $0.00 | |
| 90680 | 0% | 315 | $0.00 | |
| 90686 | 0% | 3,691 | $0.00 | |
| 96127 | 0% | 180 | $0.00 | |
| 90744 | 0% | 12 | $0.00 | |
| 94760 | 0% | 67 | $0.00 | |
| 90698 | 0% | 58 | $0.00 | |
| 0001F | 0% | 12 | $0.00 | |
| 90723 | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.